Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May 14:5:184.
doi: 10.1186/1752-1947-5-184.

Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level in a woman: a case report

Affiliations

Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level in a woman: a case report

Dimitrios Theodorou et al. J Med Case Rep. .

Abstract

Introduction: Intramuscular myxoma is a rare benign soft tissue tumor. The lack of specific symptoms and widely used laboratory tests makes the diagnosis quite difficult. We present a case of an Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level. To the best of our knowledge, there have not been any reported cases of an association of Intramuscular myxoma with tumor markers in the literature.

Case presentation: A 45-year-old Caucasian woman presented to our department for resection of a mass in her left groin area, discovered incidentally on a triplex ultrasonography of her lower extremities. The diagnosis of Intramuscular myxoma was confirmed on histopathology after the complete surgical excision of the tumor. On laboratory examination, the serum level of carbohydrate antigen 19.9 was found to be elevated, but it returned to normal six months after resection of the mass.

Conclusion: Carbohydrate antigen 19.9 is a tumor marker that increases in a variety of malignant and benign conditions. After the exclusion of all other possible reasons for carbohydrate antigen 19.9 elevation, we assumed a possible connection of carbohydrate antigen 19.9 elevation and Intramuscular myxoma, an issue that requires needs further investigation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Coronal T2-weighted MRI of left groin Intramuscular myxoma.
Figure 2
Figure 2
Axial T1-weighted MRI of left groin Intramuscular myxoma.

References

    1. Vilanova J, Woertler K, Narváez J, Barceló J, Martínez S, Villalón M, Miró J. Soft-tissue tumors update: MR imaging features according to the WHO classification. Eur Radiol. 2007;17(1):125–138. doi: 10.1007/s00330-005-0130-0. - DOI - PubMed
    1. Wakely P, Bos G, Mayerson J. The cytopathology of soft tissue myxomas, ganglia, juxta-articular myxoid lesions, and Intramuscular myxoma. Am J Clin Pathol. 2005;123(6):858–865. doi: 10.1309/39YX94KXT0T2CNUX. - DOI - PubMed
    1. Hiroyuki O, Masato F, Toshiki T, Kaoru O. Intramuscular myxoma of scalene muscle: a case report. Auris Nasus Larynx. 2004;31(3):319–322. doi: 10.1016/j.anl.2004.03.009. - DOI - PubMed
    1. Murphey M, McRae G, Fanburg-Smith J, Temple T, Levine A, Aboulafia A. Imaging of soft-tissue myxoma with emphasis on CT and MR and comparison of radiologic and pathologic findings. Radiology. 2002;225(1):215–224. doi: 10.1148/radiol.2251011627. - DOI - PubMed
    1. Nielsen GP, O'Connell JX, Rosenberg AE. Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. Am J Surg Pathol. 1998;22(10):1222–1227. doi: 10.1097/00000478-199810000-00007. - DOI - PubMed

LinkOut - more resources